Keep the latest Life Sciences earnout achievement data at your fingertips
Our three-page reference guide provides a summary of earnout achievement key findings from the 2023 SRS Acquiom Life Sciences M&A Study. The data in this guide draws from the full study of more than 380 life sciences transactions (aggregate deal value of $70.6B up-front plus $74.1B earnout potential), including milestone achievement data on more than 200 deals with at least one milestone due by mid-2023.
Download the info sheet above.
Kip is a senior director leading the SRS Acquiom thought leadership practice, the mission of which is to share resourceful content built from SRS Acquiom expertise and proprietary data. In addition to facilitating scores of interactive presentations at M&A conferences and law firms, Kip authors a plethora of articles and data studies regularly utilized by the market.
Previously, Kip was a part of the SRS Acquiom Transactional Group, where he collaborated with clients and counsel to negotiate M&A documents including purchase, escrow, payments, and other transactional agreements. Before joining SRS Acquiom, he was an attorney with a Denver-based boutique business law firm working on middle-market M&A deals.
Kip holds J.D. and M.S. (Econometrics) degrees and is a member of the Colorado bar.